Physician profile
Mithun Daniel
NPI 1508206319
$1,195.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $278 · 2021: $53.03 · 2022: $188.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $165.97 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $131.22 | 2019-2021 | |
| Amgen INC. | $115.59 | 2019 | |
| Pfizer INC. | $107.95 | 2019 | |
| Lilly USA, LLC | $99.47 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $98.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.49 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $66.14 | 2019 | |
| Gilead Sciences, INC. | $42.34 | 2020 | |
| Abbvie INC. | $39.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.84 | 2019 | |
| Eisai INC. | $33.61 | 2020 | |
| Currax Pharmaceuticals LLC | $30.99 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $29.07 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $21.36 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $20.45 | 2019 | |
| Amarin Pharma, INC. | $14.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.65 | 2020 | |
| Merck Sharp & Dohme LLC | $12.49 | 2019 | |
| Sanofi Pasteur INC. | $12.14 | 2020 | |
| Aytu Biopharma, INC. | $10.83 | 2019 | |
| Shire North American Group INC | $10.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithun Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.